<DOC>
	<DOCNO>NCT01415869</DOCNO>
	<brief_summary>The purpose study estimate proportion Ventricular Assist Device ( VAD ) patient abnormal gastrointestinal bleeding assess HemoQuant fecal occult blood test . Also , patient gastrointestinal bleeding present , summarize extent gastrointestinal bleeding ; examine behavior HemoQuant fecal occult blood test time estimate proportion VAD patient positive test prior implantation ; one week , one month , three month , six month one year post implantation , explantation VAD evaluate whether presence abnormal fecal HemoQuant test predictive future major bleed event .</brief_summary>
	<brief_title>Occult Gastrointestinal Bleeding Non-pulsatile Left Ventricular Assist Device ( VAD ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<criteria>Group 1 cross sectional study . Patients implant nonpulsatile ventricular assist device type time implantation Group 2 prospective study . Patients usual VAD indication invite participate , , opinion treat physician VAD highly likely within one month . Unwillingness provide stool sample study Unwillingness follow study endpoint . Unwillingness follow dietary restriction necessary accurate HemaQuant measurement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Ventricular Assist Device</keyword>
	<keyword>Gastrointestinal Bleeding</keyword>
	<keyword>VAD</keyword>
</DOC>